Baseline health survey of the communities around the concession area of the proposed Simandou project in Guinea

ISRCTN	ISRCTN88762301
DOI	https://doi.org/10.1186/ISRCTN88762301
Protocol serial number	N/A
Sponsor	Rio Tinto SIMFER SA (Guinea)
Funder	Rio Tinto, Simandou Iron Ore Project (Guinea)

Submission date: 15/05/2010
Registration date: 20/05/2010
Last edited: 20/05/2010

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Other

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Mark Divall
Scientific

NewFields LLC
Health Impact Assessment Unit
Chatham Road 29
Irene
Pretoria
South Africa

Phone	+27 (0)12 667-6965
Email	mdivall@newfields.com

Study information

Primary study design	Observational
Study design	Cross-sectional household-based and school-based epidemiological survey in 14 sentinel sites
Secondary study design	Cross-section survey
Study type	Participant information sheet
Scientific title	Baseline health survey of the communities around the concession area of the proposed Simandou project in Guinea: A cross-sectional household-based and school-based epidemiological survey
Study acronym	BHS Simandou Guinea
Study objectives	A baseline health survey will provide quality data for profiling the health status of communities potentially affected by a large-scale iron ore project in a remote area of Guinea. Such data will become the benchmark to monitor future project-related health impacts.
Ethics approval(s)	Approved by the National Ethics Committee for Health Research (Comite National d'Ethique pour la Recherche en Sante [CNERS]) (ref. 04/CNERS/10)
Health condition(s) or problem(s) studied	Baseline health survey (malaria, intestinal parasites, anaemia, malnutrition, hypertension)
Intervention	1. Antimalarial treatment (artesunate-amodiaquine) 2. Anthelminthic treatment (albendazole plus praziquantel) 3. Iron and vitamin supplement
Intervention type	Other
Primary outcome measure(s)	1. Anaemia prevalence (according to standard WHO criteria) 2. Malaria prevalence (according to rapid diagnostic tests) 3. Prevalence of stunting and wasting 4. Prevalence of hypertension 5. Prevalence and intensity of intestinal parasites (helminths)
Key secondary outcome measure(s)	Health-related knowledge, attitudes and practices in adult population
Completion date	03/06/2010

Eligibility

Participant type(s)	Patient
Age group	Other
Sex	All
Target sample size at registration	2240
Key inclusion criteria	1. Written informed consent by head of household 2. Written informed consent by parents and/or legal guardians for children aged <15 years 3. The following inclusion criteria will be applied according to specific surveys: 3.1. Questionnaire survey: adult population (aged >15 years) 3.2. Anaemia survey: children aged < 5 years and women in reproductive age (15-49 years) 3.3. Malaria prevalence survey: children aged < 5 years 3.4. Anthropometric survey: children aged < 5 years 3.5. Blood pressure survey: adult population (aged >15 years) 3.6. Parasite prevalence survey: school-aged children (aged 6-15 years)
Key exclusion criteria	No written informed consent
Date of first enrolment	19/05/2010
Date of final enrolment	03/06/2010

Locations

Countries of recruitment

Guinea
South Africa

Study participating centre

NewFields LLC

Irene
Pretoria
South Africa

Results and Publications

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

Study outputs

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Participant information sheet	Participant information sheet	11/11/2025	11/11/2025	No	Yes